U.S. Capital Wealth Advisors’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AXGN
ACH
FLAM
SCM
PA
U.S. Capital Wealth Advisors's AXGN Position: Q1 2023 in Review
U.S. Capital Wealth Advisors sold out of Axogen (AXGN) in Q1 2023, closing a stake of 425 shares — an estimated $4.24K sold.
U.S. Capital Wealth Advisors first reported a position in AXGN in Q4 2022 and held it in 1 quarter. The position peaked at $4.24K in Q4 2022. 130 funds tracked by Wall St. Rank hold AXGN as of Q1 2023.
- U.S. Capital Wealth Advisors reported no remaining Axogen position as of Q1 2023 after selling out during the quarter.
- U.S. Capital Wealth Advisors sold 425 Axogen shares in Q1 2023, an estimated $4.24K.
- U.S. Capital Wealth Advisors first reported a position in Axogen in Q4 2022 and held it in 1 quarter.
- U.S. Capital Wealth Advisors's Axogen position peaked at $4.24K in Q4 2022.
- 130 funds tracked by Wall St. Rank held Axogen as of Q1 2023.
Based on U.S. Capital Wealth Advisors's 13F filing for Q1 2023, filed 11 May 2023.